Alexey V. Danilov

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 31 papers. Top paper: “Integrative analysis of drug response and clinical outcome in acute myeloid leukemia”.

Integrative analysis of drug response and clinical outcome in acute myeloid leukemia

Cancer Cell(2022)10.1016/j.ccell.2022.07.002

N/A

7.1DataRank · unranked

381 citations

Nicola Long, Anna Reister Schultz, Stephen E. Kurtz, Cristina E. Tognon, Kara Johnson +89 more

METTL3-Mediated m6A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLL

Blood Cancer Discovery(2023)10.1158/2643-3230.bcd-22-0156

N/A

0.903DataRank · unranked

29 citations

Meiling Jin, Mike M. Fernandez, Kevyn L. Hart, Aijun Liao, Xinzhou Ge +16 more

Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study

Haematologica(2021)10.3324/haematol.2020.270876

N/A

0.571DataRank · unranked

44 citations

Andrew M. Evens, Alexey V. Danilov, Stephen D. Smith, Deepa Jagadeesh, Lori A. Leslie +52 more

Management of CLL patients early in the COVID‐19 pandemic: An international survey of CLL experts

American Journal of Hematology(2020)10.1002/ajh.25851

N/A

0.464DataRank · unranked

21 citations

Anthony R. Mato, John C. Byrd, Alexey V. Danilov, Brad Hedrick, Chaitra S. Ujjani +6 more

International consensus statement on diagnosis, evaluation, and research of Richter transformation: the ERIC recommendations

Blood(2025)10.1182/blood.2024028064

N/A

0.425DataRank · unranked

16 citations

Monia Marchetti, Othman Al‐Sawaf, Ohad Benjamini, Alexey V. Danilov, Matthew S. Davids +24 more

A phase 1 study of the CDK9 inhibitor voruciclib in relapsed/refractory acute myeloid leukemia and B-cell malignancies

Blood Advances(2024)10.1182/bloodadvances.2024014633

N/A

0.420DataRank · unranked

9 citations

Danielle M. Brander, Yesid Alvarado, Catherine Diefenbach, Daniel Nathan Egan, Shira Dinner +14 more

Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL

Blood Cancer Journal(2025)10.1038/s41408-025-01236-6

N/A

0.396DataRank · unranked

13 citations

Ying Huang, Sarah Miller, John N. Allan, Seema A. Bhat, David A. Bond +40 more

A phase I trial of BNC105P and ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia

eJHaem(2022)10.1002/jha2.543

N/A

0.373DataRank · unranked

5 citations

Dylan B. Ness, Alexey V. Danilov, Bridget M. Labrie, Tor D. Tosteson, Alan Eastman +3 more

Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma

Blood Advances(2022)10.1182/bloodadvances.2022009225

N/A

0.373DataRank · unranked

11 citations

Jeffrey M. Switchenko, Veronika Bachanová, James N. Gerson, Stefan K. Barta, Max J. Gordon +30 more

A sumoylation program is essential for maintaining the mitotic fidelity in proliferating mantle cell lymphoma cells

Experimental Hematology and Oncology(2022)10.1186/s40164-022-00293-y

N/A

0.360DataRank · unranked

10 citations

Pushpa Lata, Youssef Youssef, Ha Tran, Liudmyla Tsyba, Lalit Sehgal +15 more

Supervised learning of high-confidence phenotypic subpopulations from single-cell data

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.23.533712

N/A

0.324DataRank · unranked

6 citations

Canping Chen, Alexey V. Danilov, Susan Liu, Xiangnan Guan, Shunyi Du +9 more

Randomized, phase III study of early intervention with venetoclax and obinutuzumab versus delayed therapy with venetoclax and obinutuzumab in newly diagnosed asymptomatic high-risk patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): EVOLVE CLL/SLL study (SWOG S1925, NCT#04269902).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps7567

N/A

0.208DataRank · unranked

3 citations

Anna Moseley, Brian T. Hill, John M. Pagel, Mazyar Shadman, Michael Fisch +9 more

The ATR Inhibitor Elimusertib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A California Cancer Consortium Phase I Trial (NCI 10404)

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0305

N/A

0.104DataRank · unranked

1 citations

Nataliya V. Uboha, Naoko Takebe, Kit Tam, Philippe L. Bédard, Kari B. Wisinski +13 more

Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemo-immunotherapy on the SWOG S0016 trial

Haematologica(2025)10.3324/haematol.2025.288057

N/A

0.104DataRank · unranked

1 citations

Hongli Li, Mazyar Shadman, Lisa M. Rimsza, Ahmad S. Zebari, Sonali M. Smith +5 more

TRES, a validated three-factor comorbidity score, is associated with survival in older patients with mantle cell lymphoma

Haematologica(2023)10.3324/haematol.2023.283074

N/A

0DataRank · unranked

0 citations

David A. Bond, Adam S. Kittai, Neda Amirmokhtari, Abigail Steinbrunner, Allison Huffman +6 more

Incidence and Management of COVID-19 Infections in Vaccinated Patients with CLL

Blood(2023)10.1182/blood-2023-173992

N/A

0DataRank · unranked

0 citations

Ted Gooley, Tanya Siddiqi, Deborah M. Stephens, Catherine M. Broome, Stephen E. Spurgeon +18 more

MGA deletion leads to Richter’s transformation by modulating mitochondrial OXPHOS

Science Translational Medicine(2024)10.1126/scitranslmed.adg7915

N/A

0DataRank · unranked

11 citations

Bo Zhang, Tingting Liu, Meiling Jin, Kevyn L. Hart, Jibin Zhang +14 more

NEDD8-activating enzyme inhibition induces cell cycle arrest and anaphase catastrophe in malignant T-cells

Oncotarget(2021)10.18632/oncotarget.28063

N/A

0DataRank · unranked

8 citations

Olga V. Danilova, Vi Lam, Tingting Liu, Nur Bruss, Scott Best +3 more

Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy

Blood Advances(2021)10.1182/bloodadvances.2021004765

N/A

0DataRank · unranked

41 citations

Jeffrey M. Switchenko, Diego Villa, Kami J. Maddocks, Michael C. Churnetski, Alina S. Gerrie +30 more

OmicsTweezer: A distribution-independent cell deconvolution model for multi-omics Data

Cell Genomics(2025)10.1016/j.xgen.2025.100950

N/A

0DataRank · unranked

7 citations

Faming Zhao, Tao Ren, Canping Chen, Katelyn T. Byrne, Alexey V. Danilov +6 more

Global DNA methylomes reveal oncogenic-associated 5-hydroxylmethylated cytosine (5hmC) signatures in the cell-free DNA of cancer patients

medRxiv(2025)10.1101/2025.01.09.25320283

N/A

0DataRank · unranked

0 citations

Alyssa C. Lau, Rachel L. Goldfeder, Rahul Maurya, Alexey V. Danilov, Chia‐Lin Wei +1 more

813 | PHASE II INVESTIGATOR‐INITIATED TRIAL OF EPCORITAMAB‐LENALIDOMIDE IN TREATMENT NAÏVE FOLLICULAR LYMPHOMA

Hematological Oncology(2025)10.1002/hon.70096_813

N/A

0DataRank · unranked

0 citations

L. CHEN, Avyakta Kallam, J. Baird, Azra Borogovac, James Godfrey +8 more

81 | REPRESSION OF miR‐29 VIA MYC LEADS TO INCREASED CD40 SIGNALING IN TRANSFORMED FOLLICULAR LYMPHOMA (FL) AND UNFAVOURABLE PROGNOSIS IN FL

Hematological Oncology(2025)10.1002/hon.70093_81

N/A

0DataRank · unranked

0 citations

Katerina Musilova Litzmanova, Filip Kledus, Miroslav Boudný, Eva Hoferková, Sheena Sharma +28 more

Prognosis and Treatment of Plasmablastic Lymphoma in the United States: A Multicenter Retrospective Study

Research Square(2025)10.21203/rs.3.rs-7607922/v1

N/A

0DataRank · unranked

0 citations

Brian L. Egleston, Zachary AK Frosch, Ralphael Steiner, Ariela Noy, Veronica Carvajal +42 more

Dual BTK/SYK inhibition with CG-806 (luxeptinib) disrupts B-cell receptor and Bcl-2 signaling networks in mantle cell lymphoma

Cell Death and Disease(2022)10.1038/s41419-022-04684-1

N/A

0DataRank · unranked

26 citations

Tingting Liu, Nur Bruss, Carly Roleder, Vi Lam, Xiaoguang Wang +9 more

Older patients with mantle cell lymphoma (MCL): Practice patterns and predictors of survival in the rituximab era.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e20064

N/A

0DataRank · unranked

0 citations

Jeffrey M. Switchenko, Subir Goyal, Veronika Bachanová, James N. Gerson, Stefan K. Barta +15 more

Generation of a humanized afucosylated BAFF-R antibody with broad activity against human B-cell malignancies

Blood Advances(2022)10.1182/bloodadvances.2022008560

N/A

0DataRank · unranked

6 citations

Joo Y. Song, Elana Thieme, Aaron Anderson, Elizabeth Oh, Wesley A. Cheng +16 more

CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma

Molecular Cancer(2023)10.1186/s12943-023-01762-6

N/A

0DataRank · unranked

36 citations

Nur Bruss, Duanchen Sun, Edward C. Dominguez, Daniel J. Coleman, Tingting Liu +9 more

Phenotype-guided subpopulation identification from single-cell sequencing data

Research Square(2021)10.21203/rs.3.rs-493014/v1

N/A

0DataRank · unranked

2 citations

Xiangnan Guan, Amy E. Moran, David Z. Qian, Pepper Schedin, Mu‐Shui Dai +6 more

MGA deletion leads to Richter’s transformation via modulation of mitochondrial OXPHOS

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.02.07.527502

N/A

0DataRank · unranked

2 citations

Bo Zhang, Tingting Liu, Meiling Jin, Kevyn L. Hart, Jibin Zhang +7 more

S2207: RANDOMIZED PHASE II STUDY OF THE ADDITION OF TARGETED AGENTS TO TAFASITAMAB‐LENALIDOMIDE IN TRANSPLANT INELIGIBLE PATIENTS WITH RELAPSED/REFRACTORY LBCL

Hematological Oncology(2023)10.1002/hon.3166_ot22

N/A

0DataRank · unranked

1 citations

Patrick M. Reagan, H. Li, Hayder Saeed, Riha Vaidya, Joseph M. Unger +5 more